Naturalendo Tech Co Ltd (168330) - Total Liabilities

Latest as of March 2026: ₩12.53 Billion KRW ≈ $8.49 Million USD

Based on the latest financial reports, Naturalendo Tech Co Ltd (168330) has total liabilities worth ₩12.53 Billion KRW (≈ $8.49 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Naturalendo Tech Co Ltd to track the company's year-over-year net asset growth rate.

Naturalendo Tech Co Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Naturalendo Tech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Naturalendo Tech Co Ltd (168330) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Naturalendo Tech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Naturalendo Tech Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Ruanyun Edai Technology Inc. Ordinary shares
NASDAQ:RYET
USA $7.13 Million
Green Cross Medical Science Corporation
KQ:142280
Korea ₩44.56 Billion
WT Financial Group Ltd
AU:WTL
Australia AU$26.32 Million
Salter Brothers Emerging Companies Ltd
AU:SB2
Australia AU$1.98 Million
EYG Gayrimenkul Yatirim Ortakligi A.S.
IS:EYGYO
Turkey TL758.51 Million
Halcyon Technology Public Company Limited
BK:HTECH
Thailand ฿304.79 Million
Hotel Sahid Jaya Tbk
JK:SHID
Indonesia Rp548.32 Billion
Aeries Technology Inc.
NASDAQ:AERT
USA $44.48 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Naturalendo Tech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Naturalendo Tech Co Ltd (168330) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.95 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.52 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.35 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Naturalendo Tech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Naturalendo Tech Co Ltd (2014–2025)

The table below shows the annual total liabilities of Naturalendo Tech Co Ltd from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 ₩12.58 Billion
≈ $8.53 Million
+94.43%
2024-12-31 ₩6.47 Billion
≈ $4.39 Million
+3.38%
2023-12-31 ₩6.26 Billion
≈ $4.24 Million
+93.85%
2022-12-31 ₩3.23 Billion
≈ $2.19 Million
-86.91%
2018-12-31 ₩24.68 Billion
≈ $16.72 Million
-20.30%
2017-12-31 ₩30.96 Billion
≈ $20.98 Million
-19.74%
2016-12-31 ₩38.58 Billion
≈ $26.14 Million
+103.37%
2015-12-31 ₩18.97 Billion
≈ $12.86 Million
+11.13%
2014-12-31 ₩17.07 Billion
≈ $11.57 Million
--

About Naturalendo Tech Co Ltd

KQ:168330 Korea Biotechnology
Market Cap
$38.73 Million
₩57.15 Billion KRW
Market Cap Rank
#22832 Global
#1468 in Korea
Share Price
₩1810.00
Change (1 day)
+4.14%
52-Week Range
₩1738.00 - ₩1919.00
All Time High
₩1919.00
About

Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet material; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Staun… Read more